MGT5PSC: Therapeutic Goods Admin. Supply Chain Analysis Presentation

This presentation provides an overview of the Therapeutic Goods Administration (TGA), an Australian organization regulating therapeutic goods, and its supply chain issues, operational challenges, information integration problems, and sustainability concerns. It highlights issues such as poor supply chain management policies, improper control over stockpiling, and a lack of coordination, temperature control, and compliance. The presentation also outlines strategic plans to overcome these challenges, emphasizing improved coordination and adherence to organizational regulations. The analysis uses information extracted from the provided Google Site and cited references.

Procurement and Supply Chain Management:
Therapeutic Goods Administration (TGA)

Demonstrate the Google Site
https://sites.google.com/site/tgahealthorg/

Introduction to Chosen
Company
Therapeutic Goods Administration (TGA) is an
Australian based organization that regulates of
therapeutic goods
Includes of gene technology, medicines, blood
products and medical services
Works with Alpha-Parma, a generic drug manufacturing
Australian company that manufactures numerous
generic pharmaceutical medicines
Contains information about shortage of medical tools
help patients with allergic problems to save and what
they should do so as to cope with the medicine
shortages

Rationale of the chosen company
Rationale of choosing this company is TGA is
accurate for analyzing its supply and
operational issues as the company is involved
into delivery of therapeutic goods to the
customers
Easier to define the lack of supply control,
order management and outsourcing of goods
Provide accurate information across entire
chain at point and at any location
Visibility of handovers into the supply chain

Supply Issues of TGA
Poor supply chain management policies
Worst supply chain management policies make company unable to
meet with market demand
Incurred of unnecessary costs to outsource EpiPen supply from other
supply vendors to esteemed customers
Improper control over stockpiling
TGA uses of poor supply chain management strategies
Loss of control over stockpiling system of EpiPen
Unable to keep accurate track of stock in and out of stock in the
enterprise
Monopoly
Does not allow other pharmaceutical company help in selling of
injections
Should allow other companies help when required to avoid shortages

Operational issues of TGA
Lack of finding out shortage problems
Due to absence of effective supply chain management,
Canberra is facing shortage of products
Poor supply chain
Supply chain management of EpiPen is poor
Not ensure that the products are produced and supplied to
the customers on time
Lack of maintenance to optimize the stream of goods,
services, capital and information to organization
Lack of control over stockpiling
Accumulate goods for future use
Not store many sticks for future use to avoid the shortages

Information issues of
TGA
Communication disruption between the top
management and juniors
Lack of clarity of company’s goals towards the
medical staffs
Unclear flow of communication between
supplier company and customers

Integration issues of
TGA
Needs of patients are not integrated into
vision and mission of the company
Stockpiling is not effective with internal
procurement system of the company
Not proper employer and worker relationships
lead to underproduction due to shortage
problems of EpiPen injections to the patients

Sustainability issues
of TGA
There are stiff competition into the marketplace as there
are many same organization competes in Australian
marketplace
Application of outdated strategies of the supply chain due
to improper maintenance of supply chain management
Threat of new entrants into the market as new same
organization are entered into the market which are
delivering same services as TGA

Top 3 challenges occurred while
working in the assessment
Lack of coordination
There are lack of coordination problems while working into
the assessment
Unable to find details information about the supply chain of
TGA
Temperature control
Need of temperature to constant which ensure usability of
the patients
Compliance:
Unable to follow the regulations of pharmaceutical supply
chain
Lack of organizational policies which regulate framework in
medicine movements

Strategic plans to overcome
with the challenges
Proper coordination will be done with the
supervisor and teammates so as to gain more
knowledge on how to find information
Proper following of organizational regulations
framework in medicine movements

Bibliography
Brown, A. (2018, March 11). THE AGE. Retrieved March
5th, 2018, from Theage.com Australia:
https://www.theage.com.au/national/act/epipen-shortage-
hits-canberra-allergy-patients-20180309-h0x996.html
Chopra, S. (2014). Supply Chain Management (Strategy,
Planning, and Operation). New Delhi: Pearson.
DIACONU, D.-M. (2014). STRENGTHS AND WEAKNESSES
OF CURRENT SUPPLY CHAIN MANAGEMENT.
MANAGEMENT CHALLENGES FOR SUSTAINABLE
DEVELOPMENT, 15.
Grimm, C. (2013). Supply Chain Management Research.
Emerald Insight, 20.